Top 5 CRISPR Stocks To Buy

In this article, we discuss the top 5 CRISPR stocks to buy. If you want to see more stocks in this selection, check out Top 10 CRISPR Stocks to Buy. 

5. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Number of Hedge Fund Holders: 25

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming. The platform is used to program cells and enable the biological production of products like new therapeutics, food ingredients, and chemicals derived from petroleum. The company provides services to different markets, such as specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. CRISPR has the potential to help treat genetic disorders, create new crops with higher yields or better resistance to disease, and even eradicate certain diseases altogether. This makes Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) one of the top CRISPR stocks to invest in, given the potential for further collaboration with industry leaders. 

On March 5, BTIG analyst Mark Massaro maintained a Buy recommendation on Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) but decreased the price target on the shares from $4 to $3. According to the analyst’s research note, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) exceeded expectations in Q4 for its Biosecurity business but fell short for its Foundry business. The lower price target is attributed to a re-rating of multiples and reduced milestone payments. The firm also noted that Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)’s 2023 guidance does not include downstream economic capture at present, as the timing remains uncertain.

According to Insider Monkey’s fourth quarter database, 25 hedge funds were bullish on Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), compared to 24 funds in the last quarter.